Skip to main content
. 2022 Sep 4;12(9):837. doi: 10.3390/metabo12090837

Table 2.

DSPC network analysis. Degree of node and betweenness of the interrelationships calculated on the metabolites with VIP > 1 related to the early and advanced ALS patients.

Network Analysis Related to Early Patients
Label Degree Betweenness
L-Histidine 16 59.91
TG 54:5 15 58.3
L-Glutamine 15 32.01
Acetic acid 14 45.95
CE 16:0 14 40.1
Cer 42:1;O2 13 33.92
PE O-38:5 13 31.09
L-Valine 13 27.77
Malonic acid 13 23.08
L-Fucose 12 51.26
SM 41:1;O2 12 32.34
1-Methylhistidine 12 24.22
L-Arginine 12 20.99
L-Methionine 12 18.84
Betaine 11 38.48
TG 52:2 11 25.04
TG 56:6 11 24.16
Linoleamide 11 20.78
Oleamide 11 20.36
3-(3,4,5-Trimethoxyphenyl)propanoic acid 10 32.28
Cer 42:0;O3 10 19.77
TG 48:2 10 19.28
L-isoleucyl-L-proline 10 15.43
TG 52:4 10 13.13
L-Glutamic acid 10 10.19
SM(34:1) 10 4.89
Ornithine 9 15.13
Acetone 9 14.81
PC 35:2 9 11.77
3-Hydroxybutyric acid 9 7.81
Succinic acid 9 6.81
LPC(20:3) 8 31.8
Creatinine 8 13.73
Creatine 8 10.52
Isobutyric acid 8 7.92
PC 32:0 8 3.67
PC O-40:5 7 8.09
PC O-38:5 7 6.29
TG 50:2 7 2.66
L-Tryptophan 6 20.66
Citric acid 5 9.23
Indoxyl sulfate 4 6.16
LPC(18:2) 3 3.01
L-Isoleucine 3 0.35
4-Hydroxyestrone sulfate 2 0
Network analysis related to advanced patients
Label Degree Betweenness
3-Hydroxybutyric acid 10 88.58
L-Isoleucyl-L-proline 10 75.85
L-Fucose 10 70.7
Succinic acid 9 89.14
Betaine 8 74.67
TG 50:2 7 83.66
1-Methylhistidine 6 65.9
TG 48:2 6 64.41
L-Methionine 6 37.13
L-Histidine 6 32.1
Isobutyric acid 6 19.31
LPC(18:2) 5 100.12
L-Valine 5 75.3
L-Isoleucine 5 72.02
PC 32:0 5 65.74
L-Tryptophan 5 62.42
TG 52:2 5 58.58
PC O-40:5 5 54.62
Acetone 5 45.33
SM(34:1) 5 33.5
Acetic acid 5 29.88
4-Hydroxyestrone sulfate 5 29.83
Cer 42:1 5 28.68463
Creatinine 5 27.83
Malonic acid 4 65.18
TG 56:6 4 33.45
Citric acid 4 18.85
3-(3-45-Trimethoxyphenyl-propanoic acid) 3 88.1
CE 16:0 3 28.59
TG 52:4 3 21.78
L-Arginine 3 19.99
LPC(20:3) 3 15.73
PC 38:5 3 11.94
Ornithine 3 0.5
Oleamide 2 42
Creatine 2 9.23